Transverse myelitis caused by herpes zoster following COVID-19 vaccination: A case report

• Published in: World journal of clinical cases Vol. 11; no. 6; pp. 1419 - 1425
• Main Authors: Cho, Su-Yeon, Jang, Bo-Hyun, Seo, Jun-Won, Kim, Suk-Whee, Lim, Kyung-Joon, Lee, Hyun-Young, Kim, Dong-Joon
• Format: Report
• Language: English
• Published: 26.02.2023
• ISSN: 2307-8960; 2307-8960
• DOI: 10.12998/wjcc.v11.i6.1419

BACKGROUNDTransverse myelitis (TM) is characterized by sudden lower extremity progressive weakness and sensory impairment, and most patients have a history of advanced viral infection symptoms. A variety of disorders can cause TM in association with viral or nonviral infection, vascular, neoplasia, collagen vascular, and iatrogenic, such as vaccination. Vaccination has become common through the global implementation against coronavirus disease 2019 (COVID-19) and reported complications like herpes zoster (HZ) activation has increased. CASE SUMMARYThis is a 68-year-old woman who developed multiple pustules and scabs at the T6-T9 dermatome site 1 wk after vaccination with the COVID-19 vaccine (Oxford/AstraZeneca ([ChAdOx1S{recombinant}]). The patient had a paraplegia aggravation 3 wk after HZ symptoms started. Spinal magnetic resonance imaging (MRI) showed transverse myelitis at the T6-T9 Level. Treatment was acyclovir with steroids combined with physical therapy. Her neurological function was slowly restored by Day 17. CONCLUSIONHZ developed after COVID-19 vaccination, which may lead to more severe complications. Therefore, HZ treatment itself should not be delayed. If neurological complications worsen after appropriate management, an immediate diagnostic procedure, such as magnetic resonance imaging and laboratory tests, will start and should treat the neurological complications.